CAT No: CP02233
CAS No:45170-31-8
Synonyms/Alias:Boc-N-Me-Val-OH;45170-31-8;Boc-N-methyl-L-valine;N-Boc-N-methyl-L-valine;(S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylbutanoicacid;(2S)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-methylbutanoicacid;AmbotzBAA1272;N-Boc-N-methylvaline;PubChem12254;Boc-N-a-methyl-L-valine;Boc-N-|A-Methyl-L-valine;N-Boc-N-Methyl-L-Val-OH;SCHEMBL59435;KSC497E8F;15538_ALDRICH;15538_FLUKA;CTK3J7282;MolPort-003-926-843;XPUAXAVJMJDPDH-QMMMGPOBSA-N;ZINC2391126;ANW-41482;CB-645;SBB067250;AKOS015836686;AKOS015905243;45170-31-8;Boc-N-Me-Val-OH;Boc-N-methyl-L-valine;N-Boc-N-methyl-L-valine;Boc-MeVal-OH;n-(tert-butoxycarbonyl)-n-methyl-l-valine;Boc-DL-N-Me-Val-OH;(2S)-3-methyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoic acid;DTXSID10426676;(2S)-2-[(tert-Butoxy)carbonylamino]-3-methylbutanoic acid;Valine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-;Boc-N-a-methyl-L-valine;MFCD00038760;N-tert-Butoxycarbonyl-N-methyl-L-valine;N-tert-Butoxycarbonyl-N-methylvaline;Q301;(S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylbutanoic acid;(2S)-2-{(tert-butoxy)carbonylamino}-3-methylbutanoic acid;N-[(1,1-Dimethylethoxy)carbonyl]-N-methyl-L-valine;(2S)-2-[(tert-Butoxy)carbonylamino]-3-methylbutanoic Acid;N-Boc-N-methylvaline;Boc-N-Me-L-Val-OH;Boc-Nalpha-methyl-L-valine;SCHEMBL59435;DTXCID30377510;XPUAXAVJMJDPDH-QMMMGPOBSA-N;(2S)-2-[(tert-butoxycarbonyl)(methyl)amino]-3-methylbutanoic acid;AC2492;AKOS015836686;AKOS015905243;AC-8571;CS-W008976;AS-15695;BP-21374;HY-41051;Boc-N-Me-Val-OH, >=99.0% (TLC);DB-038153;EN300-298768;N-alpha-t-Butyloxycarbonyl-N-alpha-methyl-L-valine;(2S)-(tert-Butoxycarbonyl-methyl-amino)-3-methyl-butyric acid;(s)-2-(t-butoxycarbonyl(methyl)amino)-3-methylbutanoic acid;(s)-2-(tert-butoxycarbonyl(methyl)amino)-3-methylbutanoic acid;(S)-2-(tert-butoxycarbonyl-methyl-amino)-3-methyl-butyric acid;(2S)-2-[(tert-butoxy)carbonylamino]-3-methyl butanoic acid
Boc-N-α-Methyl-L-valine is a Boc-protected, α-methylated valine derivative designed for peptide chemistry where steric modulation at the amino acid backbone is required. The L-valine side chain provides the hydrophobic isopropyl functionality typical of valine-based residues, while the N-terminal Boc group supports controlled coupling strategies during protected-amino-acid assembly. The α-methyl substitution increases backbone substitution and is frequently used to influence conformational preferences and proteolytic stability trends in peptide and peptidomimetic development.
1. Peptide Backbone Substitution
Boc-N-α-Methyl-L-valine is used as a protected amino acid building block for incorporating an α-methylated valine residue into peptides and peptidomimetics via standard protected-amino-acid coupling workflows. Peptide chemists select the α-methylation to introduce steric bulk at the backbone, which can help tune local conformation and reduce undesired backbone flexibility in sequence-defined constructs. The Boc-protected amine further supports stepwise assembly under peptide synthesis conditions, enabling reliable incorporation of this residue during fragment condensation or automated synthesis campaigns.
2. Peptidomimetic SAR Intermediates
Boc-N-α-Methyl-L-valine serves as a practical intermediate for medicinal chemistry teams developing structure-activity relationship (SAR) libraries where backbone substitution is a key variable. In these programs, α-methylated amino acid residues are commonly introduced to probe how steric and conformational effects impact properties such as stability and overall molecular shape, while maintaining a valine-like hydrophobic side chain for hydrophobic interaction mapping. The protected format allows rapid progression from sequence design to downstream intermediate handling for analog synthesis and purification, supporting iterative library generation.
3. Protected Amino Acid Segment Building
Boc-N-α-Methyl-L-valine is frequently employed to prepare defined peptide segments where orthogonal handling of protected functionalities is needed during multi-step assembly. Researchers building longer sequences rely on the consistent Boc protection state to manage N-terminus reactivity during coupling cycles and to integrate this α-methylated residue into middle or terminal positions of peptide fragments. This makes the reagent useful for custom peptide manufacturing research, including the preparation of sequence-specific intermediates used in purification-driven workflows such as HPLC-based fractionation and final assembly by fragment condensation.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.